Further, AEBP1 is associated with Braak staging and the degree of amyloid deposition, suggesting it is a marker of disease progression in Alzheimer’s disease (AD) (Shijo et al., 2018; Piras et al., 2019). The gene discussed is AEBP1; the disease is early-onset autosomal dominant Alzheimer disease.